FLT1 and nasopharyngeal carcinoma: Wang et al. (2010) reported polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of NPC. Makni et al. (2016) also reported distinct association of VEGFA polymorphisms with NPC. Tian et al. (2013) found that VEGFA-ERK pathway was inactivated in NPC tumors treated with radiotherapy. Xu H.-Y. et al. (2018), Xu S. et al. (2018) suggested NPC vasculogenic mimicry formation was mediated by EBV-LMP1 via VEGFA/VEGFR1 signaling.